Katie Arnold
Katie Arnold

MANAGEMENT & STRATEGY
Lecturer of Health Enterprise Management

Print Overview

SPRIG Consulting, LLC is led by Katie Arnold, a strategic marketing professional with nearly 20 years of healthcare experience.  Katie has worked with numerous medical technology companies ranging from venture-backed start-up firms to Fortune 500 public companies.  Throughout her career, Katie has focused on the entire spectrum of marketing needs: from early stage market development strategies to downstream launch execution and commercialization efforts.

Prior to founding SPRIG, Katie was an independent marketing consultant. During this time, Katie worked with over 30 companies in the medical technology sector on a variety of projects. Acting as an interim Senior Marketing Advisor, her consulting capabilities ranged from business plan refinement & market opportunity assessments to development of marketing strategies that included corporate/product positioning and brand development. She has a close relationship with physicians and assists clients with conducting clinical thought leader interviews and advisory board meetings.  Her sweet spot for many projects is her flawless launch execution and commercialization strategy implementation in the US, EU and AP geographies. During her tenure, Katie is proud to have named over a dozen medical device products and counting.

Prior to consulting, Katie had a successful career with Guidant and Kensey Nash Corporation launching new, novel technologies, such as thrombus management catheters, embolic protection devices, and coronary stents.  As Director of Marketing at Kensey Nash, Katie played a key role in establishing the company in the Endovascular Space through a strategic corporate branding initiative and numerous product launches. At the end of her tenure at Kensey Nash, the division was sold for $24M plus product revenue royalties. While at Guidant, Katie served as a Senior Global Product Manager where she successfully led the launch of the company’s first cobalt chromium stent for small vessels, the ML MINI VISION™.  Katie also held positions in strategic corporate marketing as well as sales.

Katie holds an MBA from Northwestern University’s Kellogg Graduate School of Management where she majored in marketing, health industry management, and biotechnology. While at Kellogg, Katie was awarded the Health Industry Management Scholarship for the recognition of her leadership in the health industry.

Prior to business school, Katie spent six years working in health care risk management for the medical malpractice divisions of CNA Insurance Companies and MMI Insurance Company. In her role, Katie worked directly with physicians, hospital administrators, health care systems, and managed care organizations. Katie holds a BA from the University of Vermont.

Print Vita
Education
MBA, 2002, Kellogg School of Management, Northwestern University
BA, 1994, Environmental Studies, University of Vermont

Other Professional Experience
Founder and Principal Consultant, Sprig Consulting, LLC, 2008-present
Director of Market Development, Kensey Nash Corporation, 2005-2008
Senior Global Product Manager, Vascular Intervention, Guidant Corporation, 2001-2005
Healthcare Risk Management Consultant, CNA Insurance Companies, 1996-2000
Associate Risk Management Consultant, MMI Insurance Company, 1994-1996

 
Print Research

 
Print Teaching
Full-Time / Part-Time MBA
Medical Product Early Stage Commercialization (KIEI-911-0)

Formerly ENTR-911-0

This new course offers students an experiential learning opportunity to work directly in the commercialization process for innovative, pre-commercial medical product technologies. Students will be placed on four-to-five member teams based on their skills, experience and interests. Each team will function as consultants working with select Northwestern tech transfer companies curated by Northwestern’s INVO (Innovation and New Ventures Office). Each company will present their technology on the first day of class, after which students will select their top three choices and will be matched by the faculty advisers on a first come basis. Once matched, students will work with their respective companies to build a complete company investor deck that will be delivered to a panel of industry and finance experts at the end of the term. The insights from this hands-on course will be most beneficial to students with an interest in entrepreneurship, product design, intellectual property, early stage financing and medical product marketing.

Note: This course may not be dropped after the first week of the quarter.